Skip to content
value.today

Her M.D., Inc.

🇺🇸 Cincinnati, Ohio, USAHealth CareFounded 2020
Total raised
$26 M
2 rounds on record
Latest round
$8 M
Jun 2024
First round on record
Dec 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Her M.D., Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2024$8 MNo. 2$2 to $10 million

Her M.D., Inc.: Raise no. 2, Jun 2024

Investors in this round

2 investors had bought by the notice of Jul 11, 2024: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $10 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Series A-2 convertible Preferred Stock, including underlying shares of common stock upon conversion
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ohio

People named in the notice

  • Kathryn McAleer · Director, Executive Officer · CEO and President
  • Komel Caruso · Executive Officer
  • Peter van Riper · Executive Officer · Secretary
  • Wes Cannon · Executive Officer · Chief Financial Officer
  • Chris F. Kane · Director
  • Hannah F. Dymoke · Director
  • John F. Harris · Director
  • Sharon F. Knight · Director
  • Sunbal Z. Javaid, M.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold rounded.”

Signed by Kathryn McAleer, Chief Executive Officer and President. Source: SEC Form D, newest notice filed Jul 11, 2024. Read the notice at the SEC.

equity, optionsSEC
Dec 2022$18 MNo. 1$10 to $50 million

Her M.D., Inc.: Raise no. 1, Dec 2022

Investors in this round

6 investors had bought by the notice of Jun 5, 2023: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $19 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Series A-1 Convertible Preferred Stock, including issuance of underlying shares of common stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ohio

People named in the notice

  • Kathryn McAleer · Executive Officer, Director · CEO and President
  • Kathy Z. Lai · Executive Officer
  • Komel Z. Caruso · Executive Officer
  • Sunbal Z. Javaid, M.D. · Executive Officer, Director
  • Wes Z. Cannon · Executive Officer · CFO, Secretary, and Treasurer
  • Chris Z. Kane · Director
  • John Z. Harris · Director
  • Sharon Z. Knight · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kathryn McAleer, CEO & President. Source: SEC Form D and 1 amendment, newest notice filed Jun 5, 2023. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Her M.D., Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2024).

    SEC Form D · Jul 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2024

That is all the official record says: Her M.D., Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Her M.D., Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Her M.D., Inc.
NameRoleNamed in
Kathryn McAleerCEO and PresidentJul 2024
Komel CarusoExecutive officerJul 2024
Peter van RiperSecretaryJul 2024
Wes CannonChief Financial OfficerJul 2024
Kathy Z. LaiExecutive officerJun 2023
Komel Z. CarusoExecutive officerJun 2023
Sunbal Z. Javaid, M.D.Executive officerJun 2023
Wes Z. CannonCFO, Secretary, and TreasurerJun 2023
Chris F. KaneDirectorJul 2024
Hannah F. DymokeDirectorJul 2024
John F. HarrisDirectorJul 2024
Kathryn McAleerCEO and PresidentJul 2024
Sharon F. KnightDirectorJul 2024
Sunbal Z. Javaid, M.D.DirectorJul 2024
Chris Z. KaneDirectorJun 2023
John Z. HarrisDirectorJun 2023
Sharon Z. KnightDirectorJun 2023